NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Adherence and Clinical Correlates in Persons With HIV on TAF

CompletedN/A

Sponsor: University of Colorado, Denver

Conditions: Hiv

Countries: United States

This is an observational, 48-week, prospective study of PWH treated with TAF in which the investigators will compare TFV-DP concentrations in DBS in virologically suppressed vs. non-suppressed individuals and evaluate the utility of TFV-DP in DBS to predict future viremia. To accomplish this, the investigators will approach PWH currently taking TAF (which is being prescribed by a primary care physician) and who present to the clinic for regular HIV care and HIV VL assessment. Participants will complete up to 3 visits (at least 2 weeks apart) during the 48-week study follow-up period.

Eligibility overview

Sex: ALL

Age: 18 Years to 89 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Females or males with HIV (≥18 years), able to give informed consent and comply with study procedures who are having a blood draw as part of their regular clinical care.
2. Being prescribed TAF-based ART \>= 3 months.

Exclusion Criteria:

1\. For females, active pregnancy or intent to become pregnant.

Locations (1)

Aurora, Colorado, United States